Showing results (631-640 of 870) with videos related to
Sort By:
Pageof 87
Human Brain Mapping|October 14, 2014
Functional connectivity and neuronal variability of resting state activity in bipolar disorder--reduction and decoupling in anterior cortical midline structuresPaola Magioncalda, Matteo Martino, Benedetta Conio, et al.Journal of Parkinson'S Disease|July 11, 2022
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson's DiseaseBeatrice Orso, Dario Arnaldi, Enrico Peira, et al.Frontiers in Neurology|January 29, 2015
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT StudyFlavia Mattioli, Chiara Stampatori, Fabio Bellomi, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2022
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB)Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, et al.European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.Nature Reviews. Neurology|April 12, 2024
Neurofilaments as biomarkers in neurological disorders - towards clinical applicationMichael Khalil, Charlotte E Teunissen, Sylvain Lehmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened populationKarla Kerlikowske, Diana L Miglioretti, Rachel Ballard-Barbash, et al.International Journal of MS Care|December 22, 2016
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific CircumstancesScott D Newsome, Philip J Aliotta, Jacquelyn Bainbridge, et al.International Journal of MS Care|March 1, 2017
A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and BeyondScott D Newsome, Philip J Aliotta, Jacquelyn Bainbridge, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trialJohn R Corboy, Robert J Fox, Gary Cutter, et al.Pageof 87